Emerging in the landscape of obesity therapy, retatrutide presents a distinct method. Unlike many existing medications, retatrutide works as a twin agonist, concurrently engaging both GLP-like peptide-1 (GLP-1) and https://teganhiux501366.timeblog.net/74389185/a-new-retatrutide-a-glp-gip-sensor-agonist